• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间歇性外斜视术后患者使用 0.01%阿托品滴眼液引起的会聚过度性连续内斜视。

Convergence excess consecutive esotropia associated with 0.01% atropine eye drops usage in patients operated for intermittent exotropia.

机构信息

Department of Pediatric Refractive Errors, Jyotirmay Eye Clinic for Children and Adult Squint and Ocular Motility Laboratory, Thane; Department of Pediatric Ophthalmology, Mahatme Eye Hospital, Nagpur, Maharashtra, India.

Department of Pediatric Refractive Errors, Jyotirmay Eye Clinic for Children and Adult Squint and Ocular Motility Laboratory, Thane, Maharashtra, India.

出版信息

Indian J Ophthalmol. 2020 Apr;68(4):653-656. doi: 10.4103/ijo.IJO_1243_19.

DOI:10.4103/ijo.IJO_1243_19
PMID:32174596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7210838/
Abstract

To report convergence excess esotropia (CEET) following 0.01% atropine eye drops (Low dose atropine [LDA]). Children who developed CEET that resolved promptly after discontinuation of LDA are described. Three myopes aged 5.3 ± 1.2 years and mean sphere -4.5D were included. All were operated for intermittent exotropia earlier. Mean esotropia was +28.3PD for near and 10.6PD for distance. LDA induced high AC/A ratio and fusion normalized in 3 weeks after discontinuation of LDA. LDA should be used with caution in patients with esophoria or previously operated for intermittent exotropia. Any evidence of the emergence of a CEET should warrant discontinuation of LDA.

摘要

报告阿托品眼用制剂(低浓度阿托品)滴眼后出现集合过强性内斜视(CEET)。描述了停用低浓度阿托品后迅速消退的 CEET 患儿。纳入 3 名 5.3±1.2 岁的近视患者,平均球镜-4.5D。所有患者之前均行间歇性外斜视手术。近距斜视 28.3PD,远距斜视 10.6PD。低浓度阿托品滴眼后,AC/A 比值升高,3 周后融合恢复正常。对于内斜视或曾行间歇性外斜视手术的患者,应谨慎使用低浓度阿托品。任何 CEET 出现的迹象都应停用低浓度阿托品。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/dd9b2233c8af/IJO-68-653-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/3f2bb82a5333/IJO-68-653-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/1fe24c481a03/IJO-68-653-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/4fdd190172b8/IJO-68-653-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/2c11e0682631/IJO-68-653-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/dd9b2233c8af/IJO-68-653-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/3f2bb82a5333/IJO-68-653-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/1fe24c481a03/IJO-68-653-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/4fdd190172b8/IJO-68-653-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/2c11e0682631/IJO-68-653-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974e/7210838/dd9b2233c8af/IJO-68-653-g005.jpg

相似文献

1
Convergence excess consecutive esotropia associated with 0.01% atropine eye drops usage in patients operated for intermittent exotropia.间歇性外斜视术后患者使用 0.01%阿托品滴眼液引起的会聚过度性连续内斜视。
Indian J Ophthalmol. 2020 Apr;68(4):653-656. doi: 10.4103/ijo.IJO_1243_19.
2
Intermittent exotropia with high AC/A ratio: is it a bane to surgical cure? Some facts and fictions of the two clinical tests: occlusion of one eye and the use of +3.00 spherical lenses.高AC/A比率的间歇性外斜视:手术治愈的祸根?两种临床检查(单眼遮盖和使用+3.00球镜)的一些事实与假象
Binocul Vis Strabismus Q. 2003;18(4):209-16.
3
Surgical management of intermittent exotropia with high AC/A ratio.高AC/A比率间歇性外斜视的手术治疗
J AAPOS. 1998 Dec;2(6):330-2. doi: 10.1016/s1091-8531(98)90028-3.
4
Cyclic esotropia with development of a high accommodative convergence to accommodation ratio after surgery for intermittent exotropia.间歇性外斜视手术后出现周期性内斜视并伴有高调节性集合与调节比率的发展。
Int Ophthalmol. 2017 Aug;37(4):1069-1072. doi: 10.1007/s10792-016-0354-9. Epub 2016 Sep 15.
5
Comparison of Binocular Function and Surgical Outcomes of Tenacious Proximal Fusion and High Accommodative Convergence/Accommodation Ratio Types of Intermittent Exotropia.持续性近端融合与高调节性集合/调节比率型间歇性外斜视的双眼视功能及手术效果比较
Korean J Ophthalmol. 2018 Dec;32(6):483-487. doi: 10.3341/kjo.2018.0023.
6
Diagnosis and treatment of exotropia with a high accommodation convergence-accommodation ratio.高调节性集合-调节比率外斜视的诊断与治疗
Arch Ophthalmol. 1999 Feb;117(2):221-4. doi: 10.1001/archopht.117.2.221.
7
Medial rectus muscle pulley posterior fixation sutures in accommodative and partially accommodative esotropia with convergence excess.内直肌滑车后固定缝线在伴有集合过强的调节性和部分调节性内斜视中的应用
J AAPOS. 2012 Apr;16(2):125-30. doi: 10.1016/j.jaapos.2011.11.013.
8
Combined recession and resection surgery in the management of convergence excess esotropia with different levels of AC/A ratio.联合后徙术和切除术治疗不同AC/A比值的集合过强型内斜视
J AAPOS. 2017 Feb;21(1):7.e1-7.e7. doi: 10.1016/j.jaapos.2016.09.029. Epub 2017 Jan 17.
9
Long-term motor and sensory outcomes after surgery for the nonaccommodative component of partially refractive accommodative esotropia.部分屈光性调节性内斜视非调节成分手术后的长期运动和感觉预后
J AAPOS. 2018 Oct;22(5):356-360. doi: 10.1016/j.jaapos.2018.06.006. Epub 2018 Sep 12.
10
Brain abnormalities in infantile esotropia as predictor for consecutive exotropia.婴儿型内斜视的脑部异常作为连续性外斜视的预测指标
Strabismus. 2019 Dec;27(4):199-204. doi: 10.1080/09273972.2019.1677729. Epub 2019 Oct 22.

引用本文的文献

1
[Reversible decompensation of pediatric esophoria after atropine dose increase from 0.01 to 0.025% for myopia progression prophylaxis].[预防近视进展时阿托品剂量从0.01%增加至0.025%后小儿内隐斜的可逆性失代偿]
Ophthalmologie. 2025 Mar;122(3):231-234. doi: 10.1007/s00347-024-02150-1. Epub 2024 Dec 3.
2
Temporal Variations in Convergence Insufficiency Symptomatic Status among University Students before and after COVID-19: A Longitudinal Analysis from 2018 to 2023.COVID-19前后大学生集合不足症状状态的时间变化:2018年至2023年的纵向分析
Life (Basel). 2024 Jun 26;14(7):800. doi: 10.3390/life14070800.
3

本文引用的文献

1
Consensus statement and guidelines for use of dilute atropine sulphate in myopia control.《关于在近视防控中使用低浓度硫酸阿托品滴眼液的专家共识和建议》
Indian J Ophthalmol. 2019 Apr;67(4):461-463. doi: 10.4103/ijo.IJO_1457_18.
2
Increase in esodeviation under cycloplegia with 0.5% tropicamide and 0.5% phenylephrine mixed eye drops in patients with hyperopia and esotropia.在远视和内斜视患者中,使用0.5%托吡卡胺和0.5%去氧肾上腺素混合滴眼液进行睫状肌麻痹时内斜视度数增加。
BMC Ophthalmol. 2017 Dec 12;17(1):247. doi: 10.1186/s12886-017-0644-7.
3
Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes.
Myopia in India.
印度的近视问题。
Clin Ophthalmol. 2022 Jan 20;16:163-176. doi: 10.2147/OPTH.S349393. eCollection 2022.
4
Commentary: A drop a day, keeps myopia away?评论:每天一滴,就能远离近视?
Indian J Ophthalmol. 2020 Apr;68(4):656-657. doi: 10.4103/ijo.IJO_1940_19.
1%阿托品滴眼液对延缓印度人眼睛轴性近视进展的疗效。
Indian J Ophthalmol. 2017 Nov;65(11):1178-1181. doi: 10.4103/ijo.IJO_418_17.
4
TRANSITORY CONSECUTIVE ESOTROPIA AFTER AMITRIPTYLINE TREATMENT FOR NOCTURNAL ENURESIS -CASE REPORT.
Rom J Ophthalmol. 2015 Apr-Jun;59(2):116-8.
5
The acceptability and visual impact of 0.01% atropine in a Caucasian population.0.01%阿托品在白种人群中的可接受性和视觉影响。
Br J Ophthalmol. 2016 Nov;100(11):1525-1529. doi: 10.1136/bjophthalmol-2015-307861. Epub 2016 Feb 22.
6
[Side Effects of Low Dose Atropine].[低剂量阿托品的副作用]
Nippon Ganka Gakkai Zasshi. 2015 Nov;119(11):812-6.
7
Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.五年阿托品治疗近视临床试验 2:0.01%阿托品滴眼液治疗近视的控制效果。
Ophthalmology. 2016 Feb;123(2):391-399. doi: 10.1016/j.ophtha.2015.07.004. Epub 2015 Aug 11.
8
Maximum atropine dose without clinical signs or symptoms.无临床体征或症状时的最大阿托品剂量。
Optom Vis Sci. 2013 Dec;90(12):1467-72. doi: 10.1097/OPX.0000000000000037.
9
Use of atropine to predict the accommodative component in esotropia with hypermetropia.阿托品在远视性内斜视中预测调节成分的应用。
Indian J Ophthalmol. 2011 Nov-Dec;59(6):487-90. doi: 10.4103/0301-4738.86319.
10
Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).阿托品治疗儿童近视:0.5%、0.1%和 0.01%剂量的安全性和有效性(Atropine for the Treatment of Myopia 2)。
Ophthalmology. 2012 Feb;119(2):347-54. doi: 10.1016/j.ophtha.2011.07.031. Epub 2011 Oct 2.